[1] Ai J,Li W,Zeng R,et al.Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro［J］.Biomed Pharmacother,2016,83(2):1022-1031.
[2] Fathi A,Amani F,Davoodi M,et al.A rare presentation of primary nasopharyngeal carcinoma（NPC) in mediastinum［J］.Iran J Cancer Prev,2016,9(4):e4277.
[3] XU CM,YUAN JH,CHEN XJ,et al.Value of readout-segmented echo-planar diffusion imaging on 3.0 T MRI for predicting the early efficacy of concurrent radiochemotherapy of advanced stage nasopharyngeal carcinoma patients［J］.National Medical Journal of China,2017,97(07):496-501.［许春苗,袁军辉,陈学军,等.3.0T磁共振读出方向上的分段扩散成像技术在预测局部晚期鼻咽癌同步放化疗早期疗效中的价值［J］.中华医学杂志,2017,97(07):496-501.］
[4] Tang C,Wu F,Wang R,et al.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma:A multicenter randomized phase Ⅱ clinical trial［J］.Am J Cancer Res,2016,6(9):2064-2075.
[5] Sun Y,Li WF,Chen NY,et al.Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma:A phase 3,multicentre,randomised controlled trial［J］.Lancet Oncol,2016,17(11):1509-1520.
[6] LI KX,XIN PL,CHEN YY,et al.Dosimetric and clinical factors for predicting acute radiation oral mucositis in locally advanced nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy with concurrent chemotherapy［J］.Chinese Journal of Radiation Oncology,2017,26(03):255-260.［李凯新,辛培玲,陈媛媛,等.局部中晚期鼻咽癌IMRT同步化疗后急性放射性口腔黏膜炎的预测因素分析［J］.中华放射肿瘤学杂志,2017,26(03):255-260.］
[7] Lv X,Xia WX,Ke LR,et al.Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma［J］.Onco Targets Ther,2016,18(9):5123-5131.
[8] Jin T,Qin WF,Jiang F,et al.Interim analysis of a prospective randomized non-inferiority trial of cisplatin and fluorouracil induction chemotherapy with or without docetaxel in nasopharyngeal carcinoma［J］.Oncotarget,2016,7(28):6878-6881.
[9] CHEN HH,SU ML,ZHANG CR,et al.Clinical effect of 3D conformal radiotherapy and intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma after induction chemotherapy of docetaxel and cisplatin［J］.Medical Innovation of China,2017,14(05):53-56.［陈伙辉,苏木兰,张楚荣,等.多西他赛联合顺铂诱导化疗后三维适形调强放疗同步化疗对局部晚期鼻咽癌的初步疗效分析［J］.中国医学创新,2017,14(05):53-56.］
[10] Zhang S,Lin S,Hu L.Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma［J］.J BUON,2016,21(1):161-167.
[11] Zhang X,Du L,Zhao F,et al.A phase Ⅱ clinical trial of concurrent helical tomotherapy plus cetuximab followed by adjuvant chemotherapy with cisplatin and docetaxel for locally advanced nasopharyngeal carcinoma［J］.Int J Biol Sci,2016,12(4):446-453.
[12] YANG C.Influence of recombinant human endostatin combined concurrent chemoradiotherapy on prognosis and malignant degree of nasopharyngeal carcinoma［J］.China Journal of Modern Medicine,2017,27(03):74-78.［杨琛.重组人血管内皮抑制素联合同步放化疗治疗鼻咽癌的疗效观察［J］.中国现代医学杂志,2017,27(03):74-78.］
[13] Ou D,Blanchard P,El Khoury C,et al.Induction chemotherapy with docetaxel,cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma［J］.Oral Oncol,2016,11(62):114-121.
[14] Li WF,Chen L,Sun Y,et al.Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma［J］.Chin J Cancer,2016,35(1):94.
[15] LI W,TANG RJ,PENG JQ,et al.The analysis of ADC value's standard deviation and ROI for prediction the short-term therapeutic effect in nasopharyngeal carcinoma［J］.Journal of China Clinic Medical Imaging,2017,28(02):85-88.［李伟,汤日杰,彭俊琴,等.ROI和ADC值标准差在预测鼻咽癌近期疗效中的相关分析［J］.中国临床医学影像杂志,2017,28(02):85-88.］
[16] Nakahara S,Hanamoto A,Seo Y,et al.Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma,followed by adjuvant chemotherapy for selected patients［J］.Jpn J Clin Oncol,2016,46(10):903-910.
[17] Peng X,Gong FM,Ren M,et al.Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method［J］.Anticancer Drugs,2016,27(8):748-755.
[18] YU HY,CAO CH.MRI imaging curative effect evaluation of intensity-modulated radiotherapy combined with docetaxel and oxaliplatin chemotherapy in the treatment of 50 cases of nasopharyngeal carcinoma［J］.Chinese Journal of CT and MRI,2017,15(01):8-10,40.［余海英,曹传华.调强放疗联合多西他赛+奥沙利铂化疗治疗50例鼻咽癌的MRI影像学疗效评估［J］.中国CT和MRI杂志,2017,15(01):8-10,40.］
[19] Zhao L,Xu M,Jiang W,et al.Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma［J］.Oncotarget,2017,8(4):6763-6774.
[20] Li HM,Li P,Qian YJ,et al.A retrospective paired study:Efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma［J］.BMC Cancer,2016,16(1):946.
[21] CHEN M,SU Z.Clinical observation of thalidomide combined with concurrent chemoradiotherapy for treatment of local advanced na-sopharyngeal carcinoma［J］.Journal of Modern Medicine & Health,2017,33(03):360-363.［陈宓,苏州.沙利度胺联合同步放化疗治疗局部晚期鼻咽癌临床观察［J］.现代医药卫生,2017,33(03):360-363.］
[22] Liu T,Wu X,Wang Y,et al.Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy［J］.Oncotarget,2016,7(27):42017-42030.
[23] Zhang S,Chen J,Yang S,et al.An open-label,single-arm phase Ⅱ clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma［J］.Anticancer Drugs,2016,27(7):685-688.
[24] MA XH,WANG XH,XIU LC,et al.Nedaplatin plus fluorouracil combined with radiotherapy compared with cisplatin combined with radio-therapy in the treatment of locally advanced nasopharyngeal carcinoma［J］.The Journal of Practical Medicine,2017,33(02):181-184.［马雄辉,王晓慧,修良昌,等.奈达铂加氟尿嘧啶同期放疗与顺铂同期放疗治疗局部晚期鼻咽癌的疗效比较［J］.实用医学杂志,2017,33(02):181-184.］
[25] Galletti B,Santoro R,Mannella VK,et al.Olfactory event-related potentials:A new approach for the evaluation of olfaction in nasopharyngeal carcinoma patients treated with chemo-radiotherapy［J］.J Laryngol Otol,2016,130(5):453-461.
[26] Loong HH,Chan AC,Wong AC.Evolving evidence of the efficacy and safety of nab-paclitaxel in the treatment of cancers with squamous histologies［J］.J Cancer,2016,7(3):268-275.